iBio Inc

Exhibitor

iBio is an innovator biologics company and global leader in plant-based biologics manufacturing. The company is developing therapeutics and vaccines that target COVID-19 (IBIO-200 and IBIO-201), systematic scleroderma (IBIO-100), and classical swine fever (IBIO-400). Its FastPharming System™ combines vertical farming, automated hydroponics, and glycan engineering technologies to rapidly deliver high-quality monoclonal antibodies, vaccines, bioinks, and other proteins with direct and consistent scalability. Its subsidiary, iBio CDMO LLC, provides FastPharming Contract Development and Manufacturing Services. iBio’s FastGlycaneering Development Service™ includes an array of new glycosylation technologies for engineering high-performance recombinant proteins.

website